Nilotinib 150 MG ( DrugBank: Nilotinib )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
8ハンチントン病1

8. ハンチントン病


臨床試験数 : 242 薬物数 : 205 - (DrugBank : 62) / 標的遺伝子数 : 85 - 標的パスウェイ数 : 159
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03764215
(ClinicalTrials.gov)
November 15, 201827/11/2018Nilotinib in Huntington's DiseaseAn Open Label, Phase Ib Study to Evaluate the Impact of Low Doses of Nilotinib Treatment on Safety, Tolerability and Biomarkers in Huntington's DiseaseHuntington DiseaseDrug: Nilotinib 150 MGGeorgetown UniversityNULLRecruiting25 Years90 YearsAll10Phase 1United States